Today

Agents

Chat

Arena

Discover

More

App

ARS Pharmaceuticals schedules conference call to report Q2 2026 results - SPRY News | Rallies

ARS Pharmaceuticals schedules conference call to report Q2 2026 results

SPRY•2026-08-03

Conference call and webcast scheduled for Aug. 13

ARS Pharmaceuticals scheduled a conference call, webcast, and slide presentation for Aug. 13, 2026 at 1:30 p.m. PT (4:30 p.m. ET).
The event will cover updated strategic priorities and second-quarter 2026 financial results.
Webcast access will be available via the Events & Presentations page.

Related News

Design Therapeutics Q2 net loss narrower than expected

DSGN•2026-08-03

BXP, Inc.: BofA Global Research Raises Price Objective to $85.00 From $84.00

BXP•2026-08-03

Oncology Institute to trade on Nasdaq as STLN from Aug. 4, replacing TOI

2026-08-03

Curium Announces Definitive Agreement To Merge With Lantheus

LNTH•2026-08-03

Oncology Institute Rebrands As Starling Oncology

TOI•2026-08-03